Study Protocols Flashcards
6 cards from real SOCRA CCRP practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 6 Study Protocols flashcards as text
What is the purpose of specifying stopping rules in a clinical trial protocol?
Answer: To define predetermined criteria for early termination of the trial based on safety concerns, futility, or overwhelming efficacy
Stopping rules are predetermined statistical or clinical criteria specified in the protocol that trigger early termination of the trial if subjects face unacceptable risk, the treatment shows overwhelming benefit, or the trial is unlikely to demonstrate a meaningful effect.
What information must the protocol provide about concomitant medications?
Answer: A list of permitted, prohibited, and restricted concomitant medications along with guidelines for managing drug interactions
The protocol must specify which concomitant medications and treatments are permitted, restricted, or prohibited during the trial, along with instructions for managing subjects who require prohibited medications.
What is the difference between a primary endpoint and a secondary endpoint in a clinical trial protocol?
Answer: The primary endpoint is the main outcome measure on which the sample size is based, while secondary endpoints provide supportive evidence
The primary endpoint is the principal outcome measure that the trial is powered to evaluate and forms the basis for the sample size calculation, while secondary endpoints provide additional supportive or exploratory evidence about the treatment's effects.
How should the protocol address subject withdrawal and discontinuation?
Answer: The protocol must specify criteria for subject withdrawal, procedures for discontinuation, and the type and timing of data to be collected from withdrawn subjects
The protocol must describe the criteria that would lead to subject withdrawal, the procedures for orderly discontinuation, and what follow-up data should be collected from withdrawn subjects, including safety follow-up requirements.
What is a protocol-specified visit window and why is it important?
Answer: A defined acceptable time range around each scheduled study visit that allows for scheduling flexibility while maintaining data quality
Visit windows define the acceptable range of days around each scheduled study visit (e.g., Day 28 ± 3 days). They provide scheduling flexibility while ensuring assessments are performed at appropriate intervals to maintain the scientific validity of the collected data.
What is the role of the statistical analysis plan (SAP) in relation to the study protocol?
Answer: The SAP is a detailed document that expands on the protocol's statistical section, specifying all planned analyses, populations, and handling of missing data
The SAP is a detailed technical document that expands on the statistical considerations outlined in the protocol. It specifies the analysis populations, statistical methods, handling of missing data, interim analyses, and multiplicity adjustments, and is finalized before database lock.